About Blaze Bioscience
Blaze Bioscience is a private company based in Seattle, Washington. It has reported $115,758,374 raised in 12 offerings on Form D since October 2011. Its chief executive is Steven Daly.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 15, 2024 | Oct 21, 2024 | $8,060,000of $20.0M target | 2 | $4.0M | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Oct 6, 2022 | Oct 21, 2024 | $25,000,000fully sold | 3 | $8.3M | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Oct 7, 2021 | Oct 21, 2024 | $15,000,000fully sold | 6 | $2.5M | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Oct 30, 2020 | Oct 21, 2024 | $10,000,000fully sold | 1 | $10.0M | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Feb 1, 2019 | Feb 14, 2019amended Apr 8, 2020 | $20,230,000of $25.2M target | 38 | $532K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| May 10, 2018 | May 15, 2018 | $3,000,000of $5.0M target | 1 | $3.0M | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Oct 3, 2017 | Oct 10, 2017 | $16,108,197of $18.1M target | 32 | $503K | EquityRule 506(b) | Form D ↗ |
| Jun 8, 2017 | Jun 22, 2017 | $554,000of $5.0M target | 5 | $110K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Dec 31, 2015 | Jan 12, 2016 | $991,000of $4.9M target | 8 | $123K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Jun 14, 2013 | Jun 27, 2013amended Jun 25, 2015 | $9,711,998of $15.0M target | 27 | $359K | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Jun 6, 2012 | Jun 19, 2012 | $6,378,179of $10.7M target | 19 | $335K | Equity06 | Form D ↗ |
| Oct 3, 2011 | Oct 17, 2011 | $725,000of $1.5M target | 6 | $120K | Debt, Securities on exercise, Promissory Notes convertible into preferred stock06 | Form D ↗ |
| Total, 12 offerings | $115,758,374 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Blaze Bioscience's Form D filed Oct 21, 2024.
HF
Heather Franklin
Director
SD
Steven Daly
Chief Executive Officer and director
LH
Lawrence Hughes
Director
JT
James Towne
Executive officer and director
LL
Ludmila Lobanova
Executive officer
JO
Jan Ohrstrom
Director
Earlier filings also listed Mary Hughes (director, last listed Apr 2020), Dennis Miller (executive officer, last listed Apr 2020), Claudia Jochheim (executive officer, last listed Apr 2020), Julia Novak (executive officer, last listed Jan 2016) and James Olson (director, last listed Jan 2016).